AcroImmune Biopharmaceutical Co., Ltd. was founded by Professor Yang Liu, an internationally renowned immunologist, Fellow of the American Association for the Advancement of Science (AAAS), and founder of OncoImmune Inc. The company established Suzhou AngKang Immune Technology Co., Ltd. in the Suzhou Industrial Park in 2017 and Guangzhou AcroImmune BioTech. Co., Ltd. on Guangzhou International Bio Island in 2018.OncoC4 ImmunoPharma Group is dedicated to developing innovative immunotherapeutic drugs, focusing on the immune treatment of malignant tumors and inflammatory diseases. Currently, the company has multiple Best-in-Class and First-in-Class original new drug products in its pipeline.